Feminine Pain Relief

Description

BEYOU Period Patches are available in a package containing five patches, identified by National Drug Code (NDC) 84253-001-01. These patches are designed for topical application.

Uses and Indications

This drug is indicated for the temporary relief of minor aches and pains associated with menstrual cramps, lower pelvic pain, backache, leg cramps, sprains, and strains.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Adults and children 12 years of age and older are instructed to apply the patch to the affected area no more than two times daily. For children under 12 years of age, it is recommended to consult a doctor prior to use.

To apply the patch, first open the pouch and remove the patch. Peel off the protective film, ensuring that the sticky side is exposed. Prior to application, the skin at the site should be thoroughly dried to ensure optimal adhesion of the patch. After applying the patch to the affected area, it should remain in place as directed.

Contraindications

Use of this product is contraindicated in the following situations:

The product should not be applied to wounds or damaged skin due to the potential for irritation or adverse reactions. Additionally, the use of this product in conjunction with a heating pad is contraindicated, as this may lead to increased risk of skin irritation or burns.

Warnings and Precautions

For external use only, this product must be utilized strictly as directed to ensure safety and efficacy.

Contraindications This product should not be applied to wounds or damaged skin, nor should it be used in conjunction with a heating pad, as these practices may lead to adverse effects.

Pre-Use Consultation Healthcare professionals should advise patients to consult a physician prior to use if there is any redness present over the affected area.

Usage Guidelines While using this product, it is imperative to avoid contact with the eyes, mucous membranes, and any rashes. Additionally, patients should refrain from applying tight bandages over the treated area to prevent complications.

Monitoring and Discontinuation Patients are instructed to discontinue use and seek medical advice if the condition worsens, if symptoms persist beyond 7 days, or if symptoms resolve only to recur within a few days. Furthermore, any abnormal skin irritation following application warrants immediate consultation with a healthcare provider.

Pediatric Safety This product should be kept out of reach of children. In the event of accidental ingestion, it is crucial to seek medical assistance or contact a Poison Control Center without delay.

Side Effects

Patients using this product may experience adverse reactions that necessitate caution and appropriate management. The product is intended for external use only and should be applied strictly as directed. It is contraindicated for use on wounds or damaged skin and should not be used in conjunction with a heating pad.

Participants are advised to consult a healthcare professional prior to use if there is any redness over the affected area. During application, it is crucial to avoid contact with the eyes, mucous membranes, and any rashes. Additionally, bandaging should not be done tightly to prevent exacerbation of any potential adverse effects.

Patients should discontinue use and seek medical advice if their condition worsens, if symptoms persist for more than 7 days, or if symptoms clear up only to recur within a few days. Abnormal skin irritation following usage is also a reason to stop use and consult a healthcare provider.

It is important to keep this product out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought or contact with a Poison Control Center is recommended.

Drug Interactions

No specific drug interactions have been identified for this medication. Additionally, there are no reported interactions with laboratory tests. Therefore, no dosage adjustments or monitoring recommendations are necessary based on drug or laboratory test interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Feminine Pain Relief (menthol, unspecified form). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 12 years of age should consult a healthcare professional prior to use. For adolescents and children aged 12 years and older, the recommended application is to the affected area no more than twice daily.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population, given the lack of targeted data.

Pregnancy

There is no specific information regarding the use of this product in pregnant patients. The prescribing information does not indicate whether the product is contraindicated during pregnancy or outline any associated risks to the fetus. Additionally, there are no dosage modifications or special precautions recommended for use during pregnancy. Healthcare professionals should consider the lack of data when prescribing this product to women of childbearing potential and weigh the potential benefits against any unknown risks.

Lactation

There is no specific information available regarding the use of this medication in nursing mothers or its effects on lactation. Additionally, no data are provided concerning the excretion of this medication in breast milk or its potential effects on breastfed infants. Healthcare professionals should consider the lack of information when advising lactating mothers about the use of this medication.

Renal Impairment

Patients with renal impairment have no specific information regarding dosage adjustments, special monitoring, or safety considerations provided in the drug insert. Therefore, healthcare professionals should exercise caution when prescribing this medication to individuals with reduced kidney function, as the lack of data may impact the drug's efficacy and safety profile in this population. Regular monitoring of renal function is advisable to ensure appropriate management of therapy in these patients.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the prescribing information.

Overdosage

In the event of an overdosage, immediate medical intervention is crucial. If the substance is ingested, healthcare professionals should advise patients or caregivers to seek medical assistance or contact a Poison Control Center without delay.

Prompt action is essential to mitigate potential adverse effects associated with overdosage. Symptoms may vary depending on the specific substance involved; therefore, a thorough assessment by a medical professional is recommended to determine the appropriate course of action and management strategies.

Healthcare providers should ensure that patients are aware of the importance of timely reporting of any overdosage incidents to facilitate effective treatment and minimize risks.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this product out of reach of children to prevent accidental ingestion. Instruct patients that if the product is swallowed, they should seek medical help or contact a Poison Control Center immediately.

Patients should be informed not to use the product on wounds or damaged skin, and to avoid using it in conjunction with a heating pad. It is important to counsel patients to stop using the product and consult a doctor if their condition worsens, if symptoms persist for more than 7 days, or if symptoms clear up and then recur within a few days.

Additionally, patients should be made aware to discontinue use and seek medical advice if they experience any abnormal skin irritation after using the product. While using this product, patients should avoid contact with the eyes, mucous membranes, and any rashes. They should also be instructed not to bandage the area tightly when applying the product.

Finally, healthcare providers should recommend that patients consult a doctor before using the product if there is any redness over the affected area.

Storage and Handling

The product is supplied in various configurations, with specific NDC numbers available for identification. It is essential to store the product in a cool, dry place, avoiding direct sunlight to maintain its integrity. Additionally, the product must be protected from excessive moisture to ensure optimal quality and efficacy. Proper handling and storage conditions are crucial for preserving the product's effectiveness.

Additional Clinical Information

The medication is administered topically, with a recommended application frequency of no more than twice daily for adults and children aged 12 years and older. For children under 12 years of age, it is advised to consult a doctor prior to use. There is no additional information available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Feminine Pain Relief, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)